CPT1A and ovarian cancer: Our present study observed that depletion of TAK1 leads to decreased FASN and CPT1A expression, and consequently, this inhibition of lipid metabolic activities results in suppression of NF-κB activation in OCM cocultured ovarian cancer cells.